A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.

The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...

Wegovy: sales of weight loss injection more than double - The company said more than 45 million people were now ‘benefitting ...

Share on Pinterest LeoPatrizi/Getty Images Semaglutide is the active ingredient in Wegovy, Ozempic, and Rybelsus. Currently, only Wegovy is approved for weight loss in the United States.

Notably, semaglutide, a GLP-1 agonist, is approved as an Ozempic pre-filled pen and Rybelsus oral tablet for type II diabetes (T2D) and as a Wegovy injection for weight management. Wegovy is likely to ...

marketed as Ozempic pre-filled pen and Rybelsus oral tablet for T2D and as Wegovy injection for weight management. Wegovy is a significant contributor to Novo Nordisk's revenues. Despite supply ...

Fresh questions are being asked about the use of weight loss injections after pharmacists ... size emerged , compared to the "gorilla" of Wegovy. The two biggest selling GLP-1 drugs are branded ...

Many insurance companies do not cover weight loss injections unless they are for underlying conditions such as diabetes. Wegovy (semaglutide) is an injection medication that can help manage blood ...